Gender Differences in Bladder Cancer Treatment Decision Making
Gender Differences in Bladder Cancer Treatment Decision Making
复制标题
DOI：
10.1188/17.onf.204-209
复制
发表时间：
2017-03-01
影响因子：
1.9
通讯作者：
Berry, Donna L.
中科院分区：
文献类型：
--
作者：
Pozzar, Rachel A.;Berry, Donna L.
目的/目标：探讨膀胱癌治疗决策中的性别差异。研究方法：对访谈记录进行二次定性分析。地点：位于马萨诸塞州波士顿的一个多学科泌尿生殖肿瘤诊所（达纳法伯癌症研究所）和两个泌尿外科诊所（布莱根妇女医院和贝斯以色列女执事医疗中心）。参与者：作为原始研究的一部分，45 名患有膀胱癌的男性和 15 名女性参与了个体研究采访。参与者主要是白人，大多数人至少受过大学教育。方法：使用词频报告来识别男性和女性陈述之间的主题差异。然后，对 NVivo 9 中的所有参与者进行女性中普遍存在的结构的逐行编码。使用矩阵编码查询对性别之间的编码结果进行比较。结果：家庭在决策过程中的作用被发现是女性而非男性的主导主题。女性主要将家庭成员描述为膀胱癌治疗相关决策的促进者，但男性更有可能将家庭描述为非支持性角色。结论：结果表明，男性和女性膀胱癌患者对决策过程的影响是不同的。对于面临膀胱癌治疗相关决策的女性来说，家庭可能发挥着特别重要的作用。解释：护理膀胱癌患者的临床护士应定期评估患者的支持系统以及家庭参与决策的期望水平。对于一些膀胱癌患者来说，家庭可能会成为压力源。护士应支持所有患者的决策过程，并熟悉可为无法从家人那里获得支持的患者提供支持的资源。
Purpose/Objectives: To explore gender differences in bladder cancer treatment decision making.Research Approach: Secondary qualitative analysis of interview transcripts.Setting: One multidisciplinary genitourinary oncology clinic (Dana-Farber Cancer Institute) and two urology clinics (Brigham and Women's Hospital and Beth Israel Deaconess Medical Center) in Boston, MA.Participants: As part of the original study, 45 men and 15 women with bladder cancer participated in individual interviews. Participants were primarily Caucasian, and most had at least some college education.Methodologic Approach: Word frequency reports were used to identify thematic differences between the men's and women's statements. Line-by-line coding of constructs prevalent among women was then performed on all participants in NVivo 9. Coding results were compared between genders using matrix coding queries.Findings: The role of family in the decision-making process was found to be a dominant theme for women but not for men. Women primarily described family members as facilitators of bladder cancer treatment-related decisions, but men were more likely to describe family in a nonsupportive role.Conclusions: The results suggest that influences on the decision-making process are different for men and women with bladder cancer. Family may play a particularly important role for women faced with bladder cancer treatment-related decisions.Interpretation: Clinical nurses who care for individuals with bladder cancer should routinely assess patients' support systems and desired level of family participation in decision making. For some people with bladder cancer, family may serve as a stressor. Nurses should support the decision-making processes of all patients and be familiar with resources that can provide support to patients who do not receive it from family.